Rare gene variants and weight loss at 10 years after sleeve gastrectomy and gastric bypass - a randomized clinical trial
There were LP/SP pathogenic variants in 5% of the patients supporting the potential benefits of genetic testing to optimize targeted therapies in the future. Despite deleterious gene defects the long-term MBS outcome can be favorable.
Authors
- Sofia Grönroos (ORCID: https://orcid.org/0000-0003-1103-8584)
- Paulina T. P. Salminen (ORCID: https://orcid.org/0000-0001-6435-9264)
- Saija Hurme (ORCID: https://orcid.org/0000-0001-8821-8925)
- Outi Mäkitie (ORCID: https://orcid.org/0000-0002-4547-001X)
- Petra Loid (ORCID: https://orcid.org/0000-0002-2708-0878)
Institutions
- Karolinska University Hospital (SE)
- University of Helsinki (FI)
- University of Turku (FI)
- Helsinki University Hospital (FI)
- Turku University Hospital (FI)
Publication Details
- Journal
- Surgery for Obesity and Related Diseases
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1016/j.soard.2024.11.021
- Citations
- 2
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.15
Funders
- Lastentautien Tutkimussäätiö